Sign in →

Test ID EEPC Eastern Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid

Useful For

Aiding the diagnosis of Eastern equine encephalitis

Method Name

Immunofluorescence Assay (IFA)

Reporting Name

East Equine Enceph Ab Panel, CSF

Specimen Type

CSF


Specimen Required


Container/Tube: Sterile vial

Specimen Volume: 0.5 mL

Additional Information: This test is not available for specimens originating in New York.


Specimen Minimum Volume

0.2 mL

Specimen Stability Information

Specimen Type Temperature Time
CSF Refrigerated (preferred) 14 days
  Frozen  14 days

Clinical Information

Eastern equine encephalitis (EEE) is within the alphavirus group. It is a low-prevalence cause of human disease in the Eastern and Gulf Coast states. EEE is maintained by a cycle of mosquito/wild bird transmission, peaking in the summer and early fall, when man may become an adventitious host. The most common clinically apparent manifestation is a mild undifferentiated febrile illness, usually with headache.

 

Central nervous system involvement is demonstrated in only a minority of infected individuals, and is more abrupt and more severe than with other arboviruses, with children being more susceptible to severe disease. Fatality rates are approximately 70%.

 

Infections with arboviruses can occur at any age. The age distribution depends on the degree of exposure to the particular transmitting arthropod, relating to age, sex, and occupational, vocational, and recreational habits of the individuals. Once humans have been infected, the severity of the host response may be influenced by age.

Reference Values

IgG: <1:10

IgM: <1:10

Reference values apply to all ages.

Interpretation

Detection of organism-specific antibodies in the cerebrospinal fluid (CSF) may suggest central nervous system infection. However, these results are unable to distinguish between intrathecal antibodies and serum antibodies introduced into the CSF at the time of lumbar puncture or from a breakdown in the blood-brain barrier. The results should be interpreted with other laboratory and clinical data prior to a diagnosis of central nervous system infection.

Clinical Reference

1. Gonzalez-Scarano F, Nathanson N: Bunyaviruses. In Fields Virology. Volume 1. Second edition. Edited by BM Fields, DM Knipe. New York, Raven Press, 1990, pp 1195-1228

2. Donat JF, Rhodes KH, Groover RV, Smith TF: Etiology and outcome in 42 children with acute nonbacterial meningoencephalitis. Mayo Clin Proc 1980:55:156-160

3. Tsai TF: Arboviruses. In Manual of Clinical Microbiology. Seventh edition. Edited by PR Murray, EF Baron, MA Pfaller, et al. Washington, DC, American Society for Microbiology, 1999, pp 1107-1124

4. Calisher CH: Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994;7:89-116

Day(s) and Time(s) Performed

May through October: Monday through Friday; 9 a.m.

 

November through April: Monday, Wednesday, Friday; 9 a.m.

Analytic Time

Same day/1 day

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

86652 x 2

LOINC Code Information

Test ID Test Order Name Order LOINC Value
EEPC East Equine Enceph Ab Panel, CSF 69035-4

 

Result ID Test Result Name Result LOINC Value
26369 East Equine Enceph Ab, IgG, CSF 10897-7
26370 East Equine Enceph Ab, IgM, CSF 10899-3